HALO
Halozyme Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +21.4% ·
Aktienfluss +24.3% ·
neue Nettopositionen +17.6%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 132 | -2 | 91.18M | $6.60B | +5 | −6 |
| Q1 2026 | 136 | +1 | 88.77M | $5.36B | +7 | −7 |
| Q4 2025 | 135 | -1 | 97.38M | $6.16B | +1 | −1 |
| Q3 2025 | 22 | +1 | 49.86M | $3.66B | +1 | −1 |
| Q2 2025 | 19 | 0 | 43.24M | $2.25B | — | — |
| Q1 2025 | 16 | -1 | 15.61M | $996.39M | — | −1 |
| Q4 2024 | 17 | +3 | 17.59M | $840.95M | +4 | −1 |
| Q3 2024 | 13 | -1 | 6.97M | $398.81M | — | −1 |
| Q2 2024 | 14 | — | 8.14M | $426.06M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 7.18M | — | $343.50M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passiv) | 7.18M | — | $343.50M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passiv) | 3.06M | +0.1% | $146.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 3.06M | +0.1% | $146.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.26M | Neu | $60.37M | 0.1% | New | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.26M | Neu | $60.37M | 0.1% | New | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.26M | Neu | $60.37M | 0.1% | New | 1 | SEC ↗ |
| 8 | Norges Bank ✦ (passiv) | 1.26M | +15.2% | $60.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 1.22M | -4.1% | $58.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 1.22M | -4.1% | $58.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 992.89K | +141.3% | $47.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 831.41K | +171.2% | $39.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 831.41K | +171.2% | $39.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Capital World Investors ✦ | 748.23K | Neu | $35.77M | 0.0% | New | 1 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 414.72K | +28.0% | $19.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 247.03K | +403.0% | $11.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 95.42K | +254.5% | $4.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Millennium Management ✦ | 95.42K | +254.5% | $4.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 84.83K | Neu | $4.06M | 0.0% | New | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 57.37K | -11.9% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 57.37K | -11.9% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 57.37K | -11.9% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 57.37K | -11.9% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 52.96K | +0.8% | $2.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 52.96K | +0.8% | $2.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 52.96K | +0.8% | $2.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 27 | Gotham Asset Management ✦ | 47.44K | +9.7% | $2.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 26.11K | -89.8% | $1.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | Marshall Wace ✦ | 4.43K | Neu | $211,607 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Citadel Advisors | $60.37M | 0.1% |
| Citadel Advisors | $60.37M | 0.1% |
| Citadel Advisors | $60.37M | 0.1% |
| Capital World Investors | $35.77M | 0.0% |
| Point72 Asset Management | $4.06M | 0.0% |
| Marshall Wace | $211,607 | 0.0% |
Ausgestiegen
| Bridgewater Associates | $659,119 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 8 Inhaber, 32.79M Anteile, $43.93M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer, Director · 9.60K Ant. · $1.03M
Officer, Director · 3.20K Ant. · $344,848
Officer, Director · 7.20K Ant. · $765,778
Officer, Director · 5.70K Ant. · $587,882
Officer, Director · 9.40K Ant. · $985,816
Officer, Director · 4.90K Ant. · $509,827
Officer, Director · 900 Ant. · $89,062
Officer, Director · 500 Ant. · $50,228
Officer, Director · 2.10K Ant. · $213,709
Officer, Director · 9.00K Ant. · $922,977
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik